Status:
UNKNOWN
Prevalence of Hyperuricemia in Pakistan
Lead Sponsor:
OBS Pakistan
Conditions:
Hyperuricemia
Eligibility:
All Genders
18+ years
Brief Summary
The prevalence of hyperuricemia has rarely been investigated in developing countries Hyperuricemia, or raised serum uric acid (SUA), is the condition closely associated with gout due to the deposition...
Detailed Description
Informed consent will be obtained from all patients and their attendant coming to clinics. Those who will agree to be part of this study were asked a questionnaire about co-morbidity and symptoms. Ur...
Eligibility Criteria
Inclusion
- Informed Consent given
Exclusion
- No Informed consent provided
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2018
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03473444
Start Date
March 1 2018
End Date
April 15 2018
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Abid Naeem
Mirpur, Azad Kashmir, Pakistan